Bobby B Shih
Overview
Explore the profile of Bobby B Shih including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar S, Orcales F, Shih B, Fang X, Yin C, Yates A, et al.
Res Sq
. 2024 Sep;
PMID: 39315268
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules, abscesses, and scarring, predominantly affecting intertriginous regions and it is often underdiagnosed. This study aimed to utilize...
2.
Rafic E, Ma C, Shih B, Miller H, Yuste R, Palomero T, et al.
J Am Chem Soc
. 2024 May;
146(19):13317-13325.
PMID: 38700457
We describe the synthesis and biological testing of ruthenium-bipyridine ruxolitinib (RuBiRuxo), a photoreleasable form of ruxolitinib, a JAK inhibitor used as an antitumoral agent in cutaneous T-cell lymphomas (CTCL). This...
3.
Shih B, Ma C, Cortes J, Reglero C, Miller H, Quinn S, et al.
J Invest Dermatol
. 2024 Jan;
144(7):1579-1589.e8.
PMID: 38219917
Cutaneous T-cell lymphomas are mature lymphoid neoplasias resulting from the malignant transformation of skin-resident T-cells. A distinctive clinical feature of cutaneous T-cell lymphomas is their sensitivity to treatment with histone...
4.
Cortes J, Filip I, Albero R, Patino-Galindo J, Quinn S, Lin W, et al.
Cell Rep
. 2022 Apr;
39(3):110695.
PMID: 35443168
Peripheral T cell lymphoma not otherwise specified (PTCL-NOS) comprises heterogeneous lymphoid malignancies characterized by pleomorphic lymphocytes and variable inflammatory cell-rich tumor microenvironment. Genetic drivers in PTCL-NOS include genomic alterations affecting...
5.
Cortes J, Patrone C, Quinn S, Gu Y, Sanchez-Martin M, Mackey A, et al.
J Invest Dermatol
. 2021 Jun;
141(12):2908-2920.e7.
PMID: 34089720
Sézary syndrome is an aggressive and disseminated form of cutaneous T-cell lymphoma associated with dismal prognosis in which the histone deacetylase inhibitor romidepsin has shown remarkable activity as a single...